What smart money is saying about Kuros Biosciences
KURN.SW
No fund has written a full thesis on Kuros Biosciences in our archive, but 1 fund letter reports a position in it — most recently Goodhart Partners Global Future Leaders Fund in June 2026.
1
Reported positions
0
Bought
0
Sold
1
Letter
Position history
Every position in Kuros Biosciences on record in the archive was reported in Q2 2026, across 1 fund letter, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 1 | 0 | 0 | 0 |
Fund activity · 1 position
- June 2026
“Bonesupport and Kuros Biosciences both had a weak quarter in share price terms, but we have not seen a single downgrade to consensus estimates or company guidance for either business.”
Read the letterKuros Biosciences
Read the letters behind these Kuros Biosciences positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger